ClinicalTrials.Veeva

Menu

Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis

A

Assiut University

Status

Unknown

Conditions

Viral Myocarditis

Treatments

Diagnostic Test: ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.

Study type

Observational

Funder types

Other

Identifiers

NCT04527835
Viral myocarditis

Details and patient eligibility

About

Presentation, Clinical Course and Patterns of Myocardial Damage due to Viral Myocarditis

Full description

  1. Determine the pattern of myocarditis in hospitalized patients with acute HF within the last 3 months.
  2. Determine the pattern of broad spectrum cardiotropic viruses in patients with acute HF within the last 3 months. These viruses like enteroviruses, adenoviruses and parvo B19 virus, HBV, HCV and Covid 19 virus due to its increased prevelance nowadays.

Enrollment

18 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: All patients admitted with symptoms , signs and echocardiographic finding suggesting myocarditis within 3 months from start of the symptoms. as acute heart failure, arrhythmias, typical chest pain with ST segment deviation in ECG . dilated cardiomyopathy associated with normal Coronary Angiography, history of upper respiratory tract infection within the last 3 months.

Exclusion Criteria:

  1. Patients with significant coronary artery disease.
  2. Patient with family history suggesting familial DCMP
  3. Critically ill patients.
  4. Patients who refuse to do coronary angiography . .
  5. Patients with severe valvular heart disease.
  6. Pregnant women
  7. Patients with raised renal chemistry.
  8. Echocardiographic finding showing LVEDD more than 6.5cm

Trial design

18 participants in 1 patient group

patients suspected for viral myocarditis
Description:
All patients admitted with unexplained heart failure in the last 3 months will be investigated for viral myocarditis by the use of 12 lead ECG, echocardiography, Cardiac MRI , coronary angiography, Endomyocardial biopsy ( optional ), serological tests including ELIZA,Extraction of nucleic acid, Determination of viral genome by using PCR., Quantitative real-time PCR to assess viral load, Immunohistochemistry analysis of EMB.
Treatment:
Diagnostic Test: ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.

Trial contacts and locations

1

Loading...

Central trial contact

Amr yousif, professor; Shery Asaad, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems